SJ

Shivdas Janardhan Mirkad

Active Director Designated Partner DIN 11376057
DIN 11376057 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivdas Janardhan Mirkad

Data last updated:

Shivdas Janardhan Mirkad is a Designated Partner at Jeevansanjeevani Health Care And Research Llp (since 2025) and Partner at Jeevan Sanjeevani Trauma Care And Icu Llp (since 2025).

DIN 11376057
Primary Designation Designated Partner
First Appointment 26 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Nov 20252025Active
Partner26 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Jeevansanjeevani Health Care And Research Llp
Jeevan Sanjeevani Trauma Care And Icu Llp
Premium access

Shareholding and investment profile for Shivdas Janardhan Mirkad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivdas Janardhan Mirkad

Shivdas Janardhan Mirkad currently holds 2 directorships: Jeevansanjeevani Health Care And Research Llp (Designated Partner, since 10 Nov 2025); Jeevan Sanjeevani Trauma Care And Icu Llp (Partner, since 26 Mar 2025).

Shivdas Janardhan Mirkad was first appointed on 26 Mar 2025 as Partner at Jeevan Sanjeevani Trauma Care And Icu Llp.

The current boards of Shivdas Janardhan Mirkad's companies include Baliram Prabhakar Bagal (Jeevansanjeevani Health Care And Research Llp), Nishant Devichand Goyal (Jeevan Sanjeevani Trauma Care And Icu Llp), Yogesh Uddhavrao Bagal (Jeevan Sanjeevani Trauma Care And Icu Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available